Bryn Mawr Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bryn Mawr Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-113,752	Closed	-$260K	–	95
2017 Q4	$260K	Hold	113,752	–	–	0.34%	48
2017 Q3	$260K	Buy	113,752 +17,147	+18%	+$22.9K	0.27%	57
2017 Q2	$130K	Sell	96,605 -10,887	-10%	-$15.7K	0.15%	67
2017 Q1	$230K	Hold	107,492	–	–	0.24%	65
2016 Q4	$474K	Buy	+107,492	New	+$510K	0.48%	37

Other funds holding ARLZ

PAR Capital Management Boston, Massachusetts $3.44B AUM 28.5% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $110B AUM 36.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Salzhauer Michael $212M AUM 20.86% 1-Year Est. Return